Paclitaxel (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Paclitaxel drug offered from Fresenius Kabi USA, LLC. This Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
NON-PROPRIETARY NAME: | Paclitaxel |
SUBSTANCE NAME: | PACLITAXEL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2009-03-20 |
END MARKETING DATE: | 0000-00-00 |
Paclitaxel HUMAN PRESCRIPTION DRUG Details:
Item Description | Paclitaxel from Fresenius Kabi USA, LLC |
LABELER NAME: | Fresenius Kabi USA, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 6(mg/mL) |
START MARKETING DATE: | 2009-03-20 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63323-763_20408c51-039d-47de-913d-d719f1cfa98b |
PRODUCT NDC: | 63323-763 |
APPLICATION NUMBER: | ANDA077574 |
Other PACLITAXEL Pharmaceutical Manufacturers / Labelers: